TG Therapeutics Provides Update on FDA Meeting for GENUINE Phase 3 Trial
Oct 16, 2017 11:30 am UTC| Business
NEW YORK, Oct. 16, 2017 -- TG Therapeutics (NASDAQ:TGTX) announced today that it has met with the U.S. Food and Drug Administration (FDA) regarding the use of the results from the GENUINE Phase 3 trial to support a...
McDermott Announces Date for Third Quarter 2017 Financial Results and Conference Call
Oct 16, 2017 11:30 am UTC| Business
HOUSTON, Oct. 16, 2017 -- McDermott International, Inc. (NYSE:MDR) will report financial results for the third quarter of 2017 on Wednesday, November 1, 2017. President and Chief Executive Officer David Dickson and...
Oct 16, 2017 11:30 am UTC| Business
MENLO PARK, Calif., Oct. 16, 2017 -- A series of publications and initiatives from the genomics community demonstrates the rapid adoption of Single Molecule, Real-Time (SMRT®) Sequencing for discovering structural...
Oct 16, 2017 11:30 am UTC| Business
SAN DIEGO, Oct. 16, 2017 -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced presentations at the...
Actinium Pharmaceuticals to Present at BIO Investor Forum
Oct 16, 2017 11:30 am UTC| Business
- Actinium to present on Tuesday, October 17th at 3 PM PT NEW YORK, Oct. 16, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative...
Cutera Inc. Joined By Six Top Physicians For First Medical Advisory Board Meeting
Oct 16, 2017 11:30 am UTC| Business
BRISBANE, Calif., Oct. 16, 2017 -- Cutera, Inc. (Nasdaq:CUTR) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announces their 2017...
O2 Investment Partners Closes “Oxygen Fund”; Exceeds $100 Million Fund Target
Oct 16, 2017 11:30 am UTC| Business
BLOOMFIELD HILLS, Mich., Oct. 16, 2017 -- O2 Investment Partners (“O2”) recently closed its Oxygen Fund, exceeding its $100 million fund target. The Oxygen Fund will continue O2’s successful track record of investing in...